Actively hiring
Health & Medical Electronics
Surgical Instruments & Devices
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
LB Investment
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers

Why Suitable AI? Industries We Serve For talent patners About Blog Hiring top talent We are a team of experienced talent advisors and…

Medical Device Developmentto Enhance the Quality of Life. 再生医療機器開発.

0 ABOUT US Advancing Patient Care with Cutting-Edge Technology At Nventric, we are driving innovation in medical technology to transform…

The Medical Device Business Journal — Medical Device News & Articles | MassDevice.

Vesteck Inc. is a clinical stage medical device company, developing a platform for securing endovascular aortic repair grafts (EVAR/TEVAR)…

Qufora is a medical device company that works to enable people with chronic bowel disorders to live a better life. Your life Our…
Overview
LIVSMED is a global medical device company. We contribute to life extension of mankind by creating innovative laparoscopic instruments to treat diseases.We adhere to highest ethics while maintaining the top talents in our field.
News
Report
LivsMed Posts 51.2 Billion Won in Revenue Last Year... Growth Continues as Losses Narrow
리브스메드는 지난해 매출 511억9200만원을 기록해 전년 271억2100만원 대비 88.8% 증가했다고 27일 밝혔다. 같은 기간 당기순손실은 228억7400만원으로 전년 265억400만원보다 줄며 수익성이 개선됐다.국내 매출은 456억8400만원으로 전년 대비 94
Read more
Report
LivsMed Completes Largest KOSDAQ IPO of 2025, Raising $94 Million (135.9 Billion) to Accelerate Global and US Market Expansion
SAN DIEGO & SEOUL, South Korea, January 15, 2026--LivsMed, a minimally invasive surgical device company, has completed an initial public offering on Korea's KOSDAQ market, raising about $94 million (135.9 billion) at 55,000 per share. Upon its debut, the
Read more
Report
Livsmed files for KOSDAQ IPO targeting 1.3 trillion won valuation
Livsmed files for KOSDAQ IPO targeting 1.3 trillion won valuation Livsmed aims to raise about 136 billion won in KOSDAQ IPO as it expands global sales
Read more
Report
Livsmed clears KOSDAQ review after patent dispute win
Livsmed clears KOSDAQ review after patent dispute win Livsmed, a medical device manufacturer seeking a KOSDAQ listing, has cleared the Korea Exchange
Read more
Report
LivsMed Unveils New Robotic System with Telesurgery Capabilities: Partners with Sovato for Remote-Enabling Technology
Read more
Report

LB Investment